197 related articles for article (PubMed ID: 32487991)
1. Stratification and prediction of drug synergy based on target functional similarity.
Yang M; Jaaks P; Dry J; Garnett M; Menden MP; Saez-Rodriguez J
NPJ Syst Biol Appl; 2020 Jun; 6(1):16. PubMed ID: 32487991
[TBL] [Abstract][Full Text] [Related]
2. An integrated framework for identification of effective and synergistic anti-cancer drug combinations.
Sharma A; Rani R
J Bioinform Comput Biol; 2018 Oct; 16(5):1850017. PubMed ID: 30304987
[TBL] [Abstract][Full Text] [Related]
3. Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
Berlow NE; Rikhi R; Geltzeiler M; Abraham J; Svalina MN; Davis LE; Wise E; Mancini M; Noujaim J; Mansoor A; Quist MJ; Matlock KL; Goros MW; Hernandez BS; Doung YC; Thway K; Tsukahara T; Nishio J; Huang ET; Airhart S; Bult CJ; Gandour-Edwards R; Maki RG; Jones RL; Michalek JE; Milovancev M; Ghosh S; Pal R; Keller C
BMC Cancer; 2019 Jun; 19(1):593. PubMed ID: 31208434
[TBL] [Abstract][Full Text] [Related]
4. Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer.
Malyutina A; Majumder MM; Wang W; Pessia A; Heckman CA; Tang J
PLoS Comput Biol; 2019 May; 15(5):e1006752. PubMed ID: 31107860
[TBL] [Abstract][Full Text] [Related]
5. Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets.
Amzallag A; Ramaswamy S; Benes CH
BMC Bioinformatics; 2019 Feb; 20(1):83. PubMed ID: 30777010
[TBL] [Abstract][Full Text] [Related]
6. SNSynergy: Similarity network-based machine learning framework for synergy prediction towards new cell lines and new anticancer drug combinations.
Huangfu X; Zhang C; Li H; Li S; Li Y
Comput Biol Chem; 2024 Jun; 110():108054. PubMed ID: 38522389
[TBL] [Abstract][Full Text] [Related]
7. Quantification of Pathway Cross-talk Reveals Novel Synergistic Drug Combinations for Breast Cancer.
Jaeger S; Igea A; Arroyo R; Alcalde V; Canovas B; Orozco M; Nebreda AR; Aloy P
Cancer Res; 2017 Jan; 77(2):459-469. PubMed ID: 27879272
[TBL] [Abstract][Full Text] [Related]
8. Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients.
He L; Tang J; Andersson EI; Timonen S; Koschmieder S; Wennerberg K; Mustjoki S; Aittokallio T
Cancer Res; 2018 May; 78(9):2407-2418. PubMed ID: 29483097
[TBL] [Abstract][Full Text] [Related]
9. In silico drug combination discovery for personalized cancer therapy.
Jeon M; Kim S; Park S; Lee H; Kang J
BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
[TBL] [Abstract][Full Text] [Related]
10. Network Propagation Predicts Drug Synergy in Cancers.
Li H; Li T; Quang D; Guan Y
Cancer Res; 2018 Sep; 78(18):5446-5457. PubMed ID: 30054332
[TBL] [Abstract][Full Text] [Related]
11. Selective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs.
Uitdehaag JC; de Roos JA; van Doornmalen AM; Prinsen MB; Spijkers-Hagelstein JA; de Vetter JR; de Man J; Buijsman RC; Zaman GJ
PLoS One; 2015; 10(5):e0125021. PubMed ID: 26018524
[TBL] [Abstract][Full Text] [Related]
12. A simple gene set-based method accurately predicts the synergy of drug pairs.
Hsu YC; Chiu YC; Chen Y; Hsiao TH; Chuang EY
BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):66. PubMed ID: 27585722
[TBL] [Abstract][Full Text] [Related]
13. The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4.
Liu L; Mayes PA; Eastman S; Shi H; Yadavilli S; Zhang T; Yang J; Seestaller-Wehr L; Zhang SY; Hopson C; Tsvetkov L; Jing J; Zhang S; Smothers J; Hoos A
Clin Cancer Res; 2015 Apr; 21(7):1639-51. PubMed ID: 25589619
[TBL] [Abstract][Full Text] [Related]
14. New methods for drug synergy prediction: A mini-review.
Abbasi F; Rousu J
Curr Opin Struct Biol; 2024 Jun; 86():102827. PubMed ID: 38705070
[TBL] [Abstract][Full Text] [Related]
15. A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities.
Narayan RS; Molenaar P; Teng J; Cornelissen FMG; Roelofs I; Menezes R; Dik R; Lagerweij T; Broersma Y; Petersen N; Marin Soto JA; Brands E; van Kuiken P; Lecca MC; Lenos KJ; In 't Veld SGJG; van Wieringen W; Lang FF; Sulman E; Verhaak R; Baumert BG; Stalpers LJA; Vermeulen L; Watts C; Bailey D; Slotman BJ; Versteeg R; Noske D; Sminia P; Tannous BA; Wurdinger T; Koster J; Westerman BA
Nat Commun; 2020 Jun; 11(1):2935. PubMed ID: 32523045
[TBL] [Abstract][Full Text] [Related]
16. Computational Pipeline for Rational Drug Combination Screening in Patient-Derived Cells.
Athanasiadis P; Ianevski A; Skånland SS; Aittokallio T
Methods Mol Biol; 2022; 2449():327-348. PubMed ID: 35507270
[TBL] [Abstract][Full Text] [Related]
17. Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes.
Regan-Fendt KE; Xu J; DiVincenzo M; Duggan MC; Shakya R; Na R; Carson WE; Payne PRO; Li F
NPJ Syst Biol Appl; 2019; 5():6. PubMed ID: 30820351
[TBL] [Abstract][Full Text] [Related]
18. An In Silico Method for Predicting Drug Synergy Based on Multitask Learning.
Chen X; Luo L; Shen C; Ding P; Luo J
Interdiscip Sci; 2021 Jun; 13(2):299-311. PubMed ID: 33611781
[TBL] [Abstract][Full Text] [Related]
19. A systematic and prospectively validated approach for identifying synergistic drug combinations against malaria.
KalantarMotamedi Y; Eastman RT; Guha R; Bender A
Malar J; 2018 Apr; 17(1):160. PubMed ID: 29642892
[TBL] [Abstract][Full Text] [Related]
20. DeepSynergy: predicting anti-cancer drug synergy with Deep Learning.
Preuer K; Lewis RPI; Hochreiter S; Bender A; Bulusu KC; Klambauer G
Bioinformatics; 2018 May; 34(9):1538-1546. PubMed ID: 29253077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
